Evidence map›Paper›PMID 37555179›Full record

ArticleFrontiers in neuroimaging2022

Investigating the contribution of cytoarchitecture to diffusion MRI measures in gray matter using histology.

Madhura Baxi, Suheyla Cetin-Karayumak, George Papadimitriou, Nikos Makris, Andre van der Kouwe, Bruce Jenkins, Tara L Moore, Douglas L Rosene, Marek Kubicki, Yogesh Rathi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neuroimaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Madhura BaxiGraduate Program for Neuroscience, Boston University, Boston, MA, United States.
Suheyla Cetin-KarayumakPsychiatry Neuroimaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
George PapadimitriouCenter for Morphometric Analysis, Massachusetts General Hospital, Charlestown, MA, United States.
Nikos MakrisPsychiatry Neuroimaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Andre van der KouweMartinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States.
Bruce JenkinsMartinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States.
Tara L MooreAnatomy and Neurobiology, Boston University School of Medicine, Boston, MA, United States.
Douglas L RoseneAnatomy and Neurobiology, Boston University School of Medicine, Boston, MA, United States.
Marek KubickiPsychiatry Neuroimaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Yogesh RathiPsychiatry Neuroimaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.

Funding

Protective roles of taurine in Alzheimer's disease brainRF1AG069228 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI DEDEOGLU, ALPASLAN, JENKINS, BRUCE G · 2020 to 2020
$2.3M
NIA NIH HHS RF1 AG069228
6 · The paper itself

Abstract

Postmortem studies are currently considered a gold standard for investigating brain structure at the cellular level. To investigate cellular changes in the context of human development, aging, or disease treatment, non-invasive

Indexed as

diffusion MRIgray matterhistologyimaging biomarkersrhesus monkeyvalidation

Identifiers

PMID37555179
PMCPMC10406256

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.